Association of adiponectin promoter variants with traits and clusters of metabolic syndrome in Arabs: Family-based study

Gene

Volumn 527, Issue 2, 2013, Pages 663-669

  Zadjali, F ^a   AL Yahyaee, S ^a   Hassan, M O ^a   Albarwani, S ^a   Bayoumi, R A ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

ADIPOQ; Measured genotype analysis; Obesity; Pedigree

Indexed keywords

ADIPONECTIN;

ADULT; ARAB; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; EXTENDED FAMILY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOQ; BMI; BODY MASS INDEX; DBP; DEOXYRIBONUCLEIC ACID; DIASTOLIC BLOOD PRESSURE; DIDEOXYNUCLEOTIDES; DNA; DNTPS; HDL; HIGH DENSITY LIPOPROTEIN; HOMA-IR; HOMEOSTASIS MODEL OF ASSESSMENT-INSULIN RESISTANCE; IDF; INTERNATIONAL DIABETES FEDERATION; LDL; LOD; LOGARITHM (BASE 10) OF ODDS; LOW DENSITY LIPOPROTEIN; MEASURED GENOTYPE ANALYSIS; MGA; OBESITY; PCR; PEDIGREE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYMERASE CHAIN REACTION; PPARΓ; QTL; QUANTITATIVE TRAIT LOCUS; SBP; SEQUENTIAL OLIGOGENIC LINKAGE ANALYSIS ROUTINES; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; SOLAR; SYSTOLIC BLOOD PRESSURE; T2DM; TG; TRIGLYCERIDES; TYPE 2 DIABETES MELLITUS; VERY LOW DENSITY LIPOPROTEIN; VLDL;

ADIPONECTIN; ARABS; BASE SEQUENCE; CLUSTER ANALYSIS; DNA PRIMERS; HUMANS; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84881542717     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.06.057     Document Type: Article

References (57)

1. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062. I.D.F.E.T.F.C. Group.
2. Al-Lawati J.A., Mohammed A.J., Al-Hinai H.Q., Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 2003, 26:1781-1785.
3. Almasy L., Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 1998, 62:1198-1211.
4. An S.S., Hanley A.J., Ziegler J.T., Brown W.M., Haffner S.M., Norris J.M., Rotter J.I., Guo X., Chen Y.D., Wagenknecht L.E., Langefeld C.D., Bowden D.W., Palmer N.D. Association between ADIPOQ SNPs with plasma adiponectin and glucose homeostasis and adiposity phenotypes in the IRAS Family Study. Mol. Genet. Metab. 2012, 107:721-728.
5. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 2012, 425:560-564. (1999).
6. Bayoumi R.A., Al-Yahyaee S.A., Albarwani S.A., Rizvi S.G., Al-Hadabi S., Al-Ubaidi F.F., Al-Hinai A.T., Al-Kindi M.N., Adnan H.T., Al-Barwany H.S., Comuzzie A.G., Cai G., Lopez-Alvarenga J.C., Hassan M.O. Heritability of determinants of the metabolic syndrome among healthy Arabs of the Oman family study. Obesity (Silver Spring) 2007, 15:551-556.
7. Berg A.H., Combs T.P., Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 2002, 13:84-89.
8. Boerwinkle E., Chakraborty R., Sing C.F. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann. Hum. Genet. 1986, 50:181-194.
9. Bostrom M.A., Freedman B.I., Langefeld C.D., Liu L., Hicks P.J., Bowden D.W. Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy. Diabetes 2009, 58:499-504.
10. Bouatia-Naji N., Meyre D., Lobbens S., Seron K., Fumeron F., Balkau B., Heude B., Jouret B., Scherer P.E., Dina C., Weill J., Froguel P. ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 2006, 55:545-550.
11. Cameron A.J., Shaw J.E., Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. North Am. 2004, 33:351-375. (table of contents).
12. Cesari M., Narkiewicz K., De Toni R., Aldighieri E., Williams C.J., Rossi G.P. Heritability of plasma adiponectin levels and body mass index in twins. J. Clin. Endocrinol. Metab. 2007, 92:3082-3088.
13. Chow W.S., Cheung B.M., Tso A.W., Xu A., Wat N.M., Fong C.H., Ong L.H., Tam S., Tan K.C., Janus E.D., Lam T.H., Lam K.S. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 2007, 49:1455-1461.
14. Comuzzie A.G., Funahashi T., Sonnenberg G., Martin L.J., Jacob H.J., Black A.E., Maas D., Takahashi M., Kihara S., Tanaka S., Matsuzawa Y., Blangero J., Cohen D., Kissebah A. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J. Clin. Endocrinol. Metab. 2001, 86:4321-4325.
15. Daimon M., Oizumi T., Saitoh T., Kameda W., Hirata A., Yamaguchi H., Ohnuma H., Igarashi M., Tominaga M., Kato T., Funagata study Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 2003, 26:2015-2020.
16. Day C. Metabolic syndrome, or what you will: definitions and epidemiology. Diab. Vasc. Dis. Res. 2007, 4:32-38.
17. Fumeron F., Aubert R., Siddiq A., Betoulle D., Pean F., Hadjadj S., Tichet J., Wilpart E., Chesnier M.C., Balkau B., Froguel P., Marre M., Epidemiologic Data on the Insulin Resistance Syndrome Study Group Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004, 53:1150-1157.
18. Goyenechea E., Collins L.J., Parra D., Abete I., Crujeiras A.B., O'Dell S.D., Martinez J.A. The -11391 G/A polymorphism of the adiponectin gene promoter is associated with metabolic syndrome traits and the outcome of an energy-restricted diet in obese subjects. Horm. Metab. Res. 2009, 41:55-61.
19. Groop L. Genetics of the metabolic syndrome. Br. J. Nutr. 2000, 83(Suppl. 1):S39-S48.
20. Gu H.F., Abulaiti A., Ostenson C.G., Humphreys K., Wahlestedt C., Brookes A.J., Efendic S. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes 2004, 53(Suppl. 1):S31-S35.
21. Guo X., Saad M.F., Langefeld C.D., Williams A.H., Cui J., Taylor K.D., Norris J.M., Jinagouda S., Darwin C.H., Mitchell B.D., Bergman R.N., Sutton B., Chen Y.D., Wagenknecht L.E., Bowden D.W., Rotter J.I. Genome-wide linkage of plasma adiponectin reveals a major locus on chromosome 3q distinct from the adiponectin structural gene: the IRAS family study. Diabetes 2006, 55:1723-1730.
22. Han L.Y., Wu Q.H., Jiao M.L., Hao Y.H., Liang L.B., Gao L.J., Legge D.G., Quan H., Zhao M.M., Ning N., Kang Z., Sun H. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 2011, 54:2303-2314.
23. Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., Yamauchi T., Otabe S., Okada T., Eto K., Kadowaki H., Hagura R., Akanuma Y., Yazaki Y., Nagai R., Taniyama M., Matsubara K., Yoda M., Nakano Y., Tomita M., Kimura S., Ito C., Froguel P., Kadowaki T. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51:536-540.
24. Hassan M.O., Albarwani S., Al Yahyaee S., Al Haddabi S., Rizwi S., Jaffer A., Al-Lawati J., Cai G., Comuzzie A.G., Bayoumi R.A. A family study in Oman: large, consanguineous, polygamous Omani Arab pedigrees. Community Genet. 2005, 8:56-60.
25. Hassan M.O., Jaju D., Voruganti V.S., Bayoumi R.A., Albarwani S., Al-Yahyaee S., Aslani A., Snieder H., Lopez-Alvarenga J.C., Al-Anqoudi Z.M., Alizadeh B.Z., Comuzzie A.G. Genome-wide linkage analysis of hemodynamic parameters under mental and physical stress in extended Omani Arab pedigrees: the Oman Family Study. Twin Res. Hum. Genet. 2011, 14:257-267.
26. Heid I.M., Henneman P., Hicks A., Coassin S., Winkler T., Aulchenko Y.S., Fuchsberger C., Song K., Hivert M.F., Waterworth D.M., Timpson N.J., Richards J.B., Perry J.R., Tanaka T., Amin N., Kollerits B., Pichler I., Oostra B.A., Thorand B., Frants R.R., Illig T., Dupuis J., Glaser B., Spector T., Guralnik J., Egan J.M., Florez J.C., Evans D.M., Soranzo N., Bandinelli S., Carlson O.D., Frayling T.M., Burling K., Smith G.D., Mooser V., Ferrucci L., Meigs J.B., Vollenweider P., Dijk K.W., Pramstaller P., Kronenberg F., van Duijn C.M. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010, 208:412-420.
27. Hong Y., Pedersen N.L., Brismar K., de Faire U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am. J. Hum. Genet. 1997, 60:143-152.
28. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1595-1599.
29. Hu F.B., Doria A., Li T., Meigs J.B., Liu S., Memisoglu A., Hunter D., Manson J.E. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 2004, 53:209-213.
30. Hwang Y.C., Jee J.H., Oh E.Y., Choi Y.H., Lee M.S., Kim K.W., Lee M.K. Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans. Int. J. Cardiol. 2009, 134:313-321.
31. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52:1655-1663.
32. Karmelic I., Lovric J., Bozina T., Ljubic H., Vogrinc Z., Bozina N., Sertic J. Adiponectin level and gene variability are obesity and metabolic syndrome markers in a young population. Arch. Med. Res. 2012, 43:145-153.
33. Kolovou G.D., Anagnostopoulou K.K., Salpea K.D., Mikhailidis D.P. The prevalence of metabolic syndrome in various populations. Am J. Med. Sci. 2007, 333:362-371.
34. Lindsay R.S., Funahashi T., Hanson R.L., Matsuzawa Y., Tanaka S., Tataranni P.A., Knowler W.C., Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57-58.
35. Lindsay R.S., Funahashi T., Krakoff J., Matsuzawa Y., Tanaka S., Kobes S., Bennett P.H., Tataranni P.A., Knowler W.C., Hanson R.L. Genome-wide linkage analysis of serum adiponectin in the Pima Indian population. Diabetes 2003, 52:2419-2425.
36. Ling H., Waterworth D.M., Stirnadel H.A., Pollin T.I., Barter P.J., Kesaniemi Y.A., Mahley R.W., McPherson R., Waeber G., Bersot T.P., Cohen J.C., Grundy S.M., Mooser V.E., Mitchell B.D. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 2009, 17:737-744.
37. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001, 50:2094-2099.
38. Meigs J.B., Wilson P.W., Fox C.S., Vasan R.S., Nathan D.M., Sullivan L.M., D'Agostino R.B. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 2006, 91:2906-2912.
39. Menzaghi C., Trischitta V., Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007, 56:1198-1209.
40. Morandi A., Maffeis C., Lobbens S., Bouatia-Naji N., Heude B., Pinelli L., Meyre D., Froguel P. Early detrimental metabolic outcomes of rs17300539-A allele of ADIPOQ gene despite higher adiponectinemia. Obesity (Silver Spring) 2010, 18:1469-1473.
41. Mori Y., Otabe S., Dina C., Yasuda K., Populaire C., Lecoeur C., Vatin V., Durand E., Hara K., Okada T., Tobe K., Boutin P., Kadowaki T., Froguel P. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 2002, 51:1247-1255.
42. Moskvina V., Schmidt K.M. On multiple-testing correction in genome-wide association studies. Genet. Epidemiol. 2008, 32:567-573.
43. Poitou C., Lacorte J.M., Coupaye M., Bertrais S., Bedel J.F., Lafon N., Bouillot J.L., Galan P., Borson-Chazot F., Basdevant A., Coussieu C., Clement K. Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obes. Surg. 2005, 15:11-23.
44. Schaffler A., Langmann T., Palitzsch K.D., Scholmerich J., Schmitz G. Identification and characterization of the human adipocyte apM-1 promoter. Biochim. Biophys. Acta 1998, 1399:187-197.
45. Schwarz P.E., Towers G.W., Fischer S., Govindarajalu S., Schulze J., Bornstein S.R., Hanefeld M., Vasseur F. Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 2006, 29:1645-1650.
46. Stumvoll M., Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes 2002, 51:2341-2347.
47. Sun H., Gong Z.C., Yin J.Y., Liu H.L., Liu Y.Z., Guo Z.W., Zhou H.H., Wu J., Liu Z.Q. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with type 2 diabetes and rosiglitazone response in Chinese patients. Br. J. Clin. Pharmacol. 2008, 65:917-926.
48. Tan K.C., Xu A., Chow W.S., Lam M.C., Ai V.H., Tam S.C., Lam K.S. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J. Clin. Endocrinol. Metab. 2004, 89:765-769.
49. Tanko L.B., Siddiq A., Lecoeur C., Larsen P.J., Christiansen C., Walley A., Froguel P. ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity. Obes. Res. 2005, 13:2113-2121.
50. Therneau T A.E., Sinnwell J., Schaid D., McDonnell S. kinship2: pedigree functions. R package version 1.3.3 2011.
51. Vasseur F., Helbecque N., Dina C., Lobbens S., Delannoy V., Gaget S., Boutin P., Vaxillaire M., Lepretre F., Dupont S., Hara K., Clement K., Bihain B., Kadowaki T., Froguel P. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum. Mol. Genet. 2002, 11:2607-2614.
52. Vasseur F., Helbecque N., Lobbens S., Vasseur-Delannoy V., Dina C., Clement K., Boutin P., Kadowaki T., Scherer P.E., Froguel P. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia 2005, 48:892-899.
53. Warodomwichit D., Shen J., Arnett D.K., Tsai M.Y., Kabagambe E.K., Peacock J.M., Hixson J.E., Straka R.J., Province M.A., An P., Lai C.Q., Parnell L.D., Borecki I.B., Ordovas J.M. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity (Silver Spring) 2009, 17:510-517.
54. Wassel C.L., Pankow J.S., Jacobs D.R., Steffes M.W., Li N., Schreiner P.J. Variants in the adiponectin gene and serum adiponectin: the Coronary Artery Development in Young Adults (CARDIA) Study. Obesity (Silver Spring) 2010, 18:2333-2338.
55. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86:1930-1935.
56. Wilson S.R., Sabatine M.S., Wiviott S.D., Ray K.K., De Lemos J.A., Zhou S., Rifai N., Cannon C.P., Morrow D.A. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). Am. Heart J. 2011, 161:1147-1155. T.S. Group, (e1141).
57. Yang W.S., Jeng C.Y., Wu T.J., Tanaka S., Funahashi T., Matsuzawa Y., Wang J.P., Chen C.L., Tai T.Y., Chuang L.M. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 2002, 25:376-380.